Apr 12, 2018 12:01 pm UTC| Business
CAMBRIDGE, Mass., April 12, 2018 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Apr 12, 2018 12:01 pm UTC| Business
Initiation of Phase 2b Trial on Track for Q3 2018 SOUTH SAN FRANCISCO, Calif., April 12, 2018 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical company focused on developing novel...
Apr 12, 2018 12:01 pm UTC| Business
DALLAS, April 12, 2018 -- eTrueNorth, the U.S.-based healthcare technology and compliance solution provider for CLIA-waived laboratories, is the only organization that offers a cloud-based software solution designed to...
Pulse Secure Launches vADC Products for Microsoft Azure
Apr 12, 2018 12:01 pm UTC| Business
SAN JOSE, Calif., April 12, 2018 -- Pulse Secure, a leader in Secure Access solutions for people, devices, things and services, today announced that its virtual Application Delivery Controller (vADC) products are now...
Apr 12, 2018 12:01 pm UTC| Business
QUEBEC CITY, April 12, 2018 -- H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) (TSX-V:HEO) (Alternext:MNEMO:ALHEO) (OTCQX:HEOFF) is proud to announce that it has partnered with Senrio, Inc., provider of the...
CPhI North America Announces Second Women in Leadership Forum
Apr 12, 2018 12:01 pm UTC| Business
NEW YORK, April 12, 2018 -- Building on the success of last year’s inaugural Women in Leadership Forum, CPhI North America, the only event to bring the complete North American pharma supply chain together, today...
Adaptimmune Announces Changes to Board of Directors
Apr 12, 2018 12:01 pm UTC| Business
PHILADELPHIA, Pa. and OXFORD, U.K., April 12, 2018 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that, in a planned transition, John Furey has been appointed...